Rapid induction of antigen-specific CD4+ T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination
Mark M. Painter(Translational Therapeutics (United States)), E. John Wherry(Parker Institute for Cancer Immunotherapy), Philip Hicks(University of Pennsylvania), Alessandro Sette(La Jolla Institute for Immunology), Christopher M. McAllister(University of Pennsylvania), Michael R. Betts(University of Pennsylvania), Jacob T. Hamilton, Sarah Dysinger(University of Pennsylvania), Ramin S. Herati(University of Pennsylvania), Sigrid Gouma(University of Pennsylvania), Scott E. Hensley(University of Pennsylvania), Divij Mathew(Parker Institute for Cancer Immunotherapy), Derek A. Oldridge(California University of Pennsylvania), Paul Bates(University of Pennsylvania), Sharon Adamski(United States Military Academy), Jeanette Dougherty(Translational Therapeutics (United States)), Allison R. Greenplate(California University of Pennsylvania), Daniela Weiskopf(Federal Office for Radiation Protection), Rishi R. Goel(University of Pennsylvania), Josephine R. Giles(Parker Institute for Cancer Immunotherapy), Kendall A. Lundgreen(University of Pennsylvania), Scott W. Korte(University of Pennsylvania), Oliva Kuthuru(Translational Therapeutics (United States)), Amy E. Baxter(Translational Therapeutics (United States)), Amanda Hicks(University of Pennsylvania), Alba Grifoni(La Jolla Institute for Immunology), Sherea Long(University of Pennsylvania), Leticia Kuri-Cervantes(University of Pennsylvania), Sokratis A. Apostolidis(University of Pennsylvania), Madison E. Weirick(University of Pennsylvania), Kurt D’Andrea(University of Pennsylvania), Ajinkya Pattekar(University of Pennsylvania)
Cited by 519
Related Papers
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
|Cell|2020|4k
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
|Nature|2010|1.8k
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
|Science|2020|1.7k
T cell responses in patients with COVID-19
|Nature reviews. Immunology|2020|873